SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-17-000342
Filing Date
2017-03-22
Accepted
2017-03-22 14:19:19
Documents
2
Period of Report
2017-03-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT f8k032117_8k.htm 8-K 10915
2 EXHIBIT 99.1 PRESS RELEASE f8k032117_ex99z1.htm EX-99.1 9720
  Complete submission text file 0001078782-17-000342.txt   21849
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 17706376
SIC: 2834 Pharmaceutical Preparations